News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
275 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity
Migraine headaches can be reduced in frequency and severity by atogepant, an oral therapy developed by AbbVie. So migraines will be gone sooner than we think.
June 3, 2021
·
4 min read
·
Gail Dutton
Business
Experts: Previous COVID-19 Infection Not a ‘Get Out Of Jail Free’ Card
Importantly, the researchers recovered virus that they were able to culture, indicating a high risk for transmissibility.
June 3, 2021
·
4 min read
·
Heather McKenzie
Bio NC
Research Roundup: A Complete Human Genome Sequenced and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
June 3, 2021
·
5 min read
·
Mark Terry
Drug Development
White House Science Chief Wants to Nullify Next Pandemic Within 100 Days
The nation’s top science adviser believes the country’s renewed enthusiasm for science may pave the way for plug-and-play vaccines that can nullify the next pandemic before it starts.
June 3, 2021
·
2 min read
·
Brandon May
Career Advice
Growing Your Emotional Intelligence At Workplace to Become an Effective Employee
Do you know that growing emotional intelligence at workplace can be beneficial for career growth? If not, have a look at the article and learn some tips.
June 3, 2021
·
4 min read
·
Hannah Harshman
Drug Development
Sanofi ASCO Preview: Addressing Unmet Needs in Breast Cancer
Sanofi’s experimental breast cancer treatment amcenestrant in combination with Pfizer’s Ibrance is showing promising anti-tumor activity in postmenopausal women with metastatic breast cancer.
June 3, 2021
·
3 min read
·
Alex Keown
Deals
“SPAC King” Drops a Cool $800 Million to Launch an Array of Biotechs
Venture capitalist Chamath Palihapitiya is raising $800 million to finance four more special purpose acquisition companies that will be focused on taking biotech companies public.
June 3, 2021
·
2 min read
·
Alex Keown
Career Advice
Career Development Initiatives that Can Work in Favor of Millennials
A well-designed career development program provides the right guidance and training for workers to improve their professional careers.
June 3, 2021
·
2 min read
·
Brandi Marcene
Drug Development
Protagonist, Janssen Win Breakthrough Therapy Designation for Oncology Candidates
Shares of Protagonist Therapeutics climbed nearly 4% in premarket trading after the company announced its lead drug candidate rusfertide snagged Breakthrough Therapy Designation from the U.S. FDA.
June 3, 2021
·
3 min read
·
Alex Keown
Drug Development
With Action Date Imminent, Biogen’s Aducanumab Invokes Hope and Skepticism
Alzheimer’s patients and their families wait with hope that this will mean some offer of treatment, while physicians that treat Alzheimer’s patients are mulling the implications of the drug, often with hesitancy and skepticism.
June 3, 2021
·
4 min read
·
Mark Terry
1 of 28
Next